Oseltamivir Phosphate
NDC 0527-5137, oseltamivir phosphate, suspension, from Lannett Company, Inc..
- Product NDC
- 0527-5137
- Status
- Listed
- Labeler
- Lannett Company, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213594
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0527-5137 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OSELTAMIVIR PHOSPHATE6 mg/mL
Pharmacologic classes
Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0527-5137-62 | 00527513762 | 1 BOTTLE, PLASTIC in 1 CARTON (0527-5137-62) / 60 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/005b2784-e410-a50c-e063-6394a90a881cNADAC price for package 00527513762
GET /v1/drugs/nadac/00527513762
Use it
Look up 0527-5137 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0527-5137 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0527-5137. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.